1. Home
  2. TLPH vs ACXP Comparison

TLPH vs ACXP Comparison

Compare TLPH & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLPH
  • ACXP
  • Stock Information
  • Founded
  • TLPH 2005
  • ACXP 2017
  • Country
  • TLPH United States
  • ACXP United States
  • Employees
  • TLPH N/A
  • ACXP N/A
  • Industry
  • TLPH Biotechnology: Pharmaceutical Preparations
  • ACXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • TLPH Health Care
  • ACXP Health Care
  • Exchange
  • TLPH Nasdaq
  • ACXP Nasdaq
  • Market Cap
  • TLPH 9.6M
  • ACXP 9.0M
  • IPO Year
  • TLPH 2011
  • ACXP 2021
  • Fundamental
  • Price
  • TLPH $0.59
  • ACXP $0.46
  • Analyst Decision
  • TLPH Strong Buy
  • ACXP Strong Buy
  • Analyst Count
  • TLPH 2
  • ACXP 1
  • Target Price
  • TLPH $4.50
  • ACXP $12.00
  • AVG Volume (30 Days)
  • TLPH 48.2K
  • ACXP 477.1K
  • Earning Date
  • TLPH 03-18-2025
  • ACXP 03-18-2025
  • Dividend Yield
  • TLPH N/A
  • ACXP N/A
  • EPS Growth
  • TLPH N/A
  • ACXP N/A
  • EPS
  • TLPH N/A
  • ACXP N/A
  • Revenue
  • TLPH $281,000.00
  • ACXP N/A
  • Revenue This Year
  • TLPH N/A
  • ACXP N/A
  • Revenue Next Year
  • TLPH N/A
  • ACXP N/A
  • P/E Ratio
  • TLPH N/A
  • ACXP N/A
  • Revenue Growth
  • TLPH N/A
  • ACXP N/A
  • 52 Week Low
  • TLPH $0.50
  • ACXP $0.43
  • 52 Week High
  • TLPH $1.27
  • ACXP $3.33
  • Technical
  • Relative Strength Index (RSI)
  • TLPH 45.21
  • ACXP 30.04
  • Support Level
  • TLPH $0.54
  • ACXP $0.60
  • Resistance Level
  • TLPH $0.60
  • ACXP $0.67
  • Average True Range (ATR)
  • TLPH 0.06
  • ACXP 0.07
  • MACD
  • TLPH -0.00
  • ACXP -0.03
  • Stochastic Oscillator
  • TLPH 25.00
  • ACXP 6.99

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.

Share on Social Networks: